Related Experiment Videos
[Pulmonary aspects in alpha-1-antitrypsin deficiency]
Luiza Erika Schmid Melo Neto1, Cyro Teixeira da Silva Junior, Gilberto Perez Cardoso
1Universidade Federal Fluminense, Niterói, Estado do Rio de Janeiro, Brasil.
Revista Portuguesa De Pneumologia
|June 18, 2004
Summary
Alpha-1-antitrypsin deficiency is a genetic disorder, primarily affecting individuals of European descent. It often leads to chronic obstructive pulmonary disease, especially in smokers, and is frequently underdiagnosed.
Area of Science:
- Genetics and наследственные заболевания
- Pulmonology
- Epidemiology
Context:
- Alpha-1-antitrypsin deficiency (AATD) is an inherited condition with a significant prevalence in European populations.
- The ZZ phenotype is the most common severe deficiency type.
- AATD is a leading cause of lung disease, particularly chronic obstructive pulmonary disease (COPD).
Purpose:
- To summarize the key aspects of Alpha-1-antitrypsin deficiency.
- To highlight its genetic basis, prevalence, and clinical manifestations.
- To underscore the association with COPD and the impact of smoking.
Summary:
- AATD is an autosomal recessive disorder, predominantly affecting individuals of European origin, with a prevalence similar to cystic fibrosis.
- While some individuals remain asymptomatic, the most common and severe consequence is chronic obstructive pulmonary disease (COPD), significantly exacerbated by tobacco smoking.
- Studies indicate that AATD is widely underdiagnosed, suggesting a need for increased awareness and diagnostic efforts.
- Various therapeutic strategies are under investigation for managing this deficiency.
Impact:
- Increases awareness of Alpha-1-antitrypsin deficiency as a significant genetic disorder.
- Highlights the underdiagnosis of AATD and its link to COPD.
- Emphasizes the critical role of smoking cessation for affected individuals.